# Safety and Efficacy of DAV132 in Patients at High-Risk for Clostridium Difficile Infection (CDI)

> **NCT03710694** · NA · COMPLETED · sponsor: **Da Volterra** · enrollment: 260 (actual)

## Conditions studied

- Clostridium Difficile Infection

## Interventions

- **DEVICE:** DAV132

## Key facts

- **NCT ID:** NCT03710694
- **Lead sponsor:** Da Volterra
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-31
- **Primary completion:** 2019-08-09
- **Final completion:** 2019-08-09
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2019-08-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03710694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03710694, "Safety and Efficacy of DAV132 in Patients at High-Risk for Clostridium Difficile Infection (CDI)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03710694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*